Skip to main content
Top
Published in: Esophagus 2/2022

01-04-2022 | Esophageal Cancer | Original Article

Esophageal wall thickness on CT scans: can it predict the T stage of primary thoracic esophageal squamous cell carcinoma?

Authors: Yue Wang, Yong Huang, Qi-yu Zhao, Xiao-qin Li, Ling Wang, Ning-ning Wang, Jin-zhi Wang, Qing Wang

Published in: Esophagus | Issue 2/2022

Login to get access

Abstract

Background

CT is the most commonly used method to stage esophageal cancer (EC). However, the reported CT T-staging criteria for EC are controversial.

Purpose

To determine and validate the optimal esophageal wall thickness (EWT) threshold on CT to distinguish lesions with different T stages in esophageal squamous cell carcinoma (ESCC) patients.

Methods

One thousand, one hundred-two consecutive patients with histopathologically confirmed ESCC between July 2014 and April 2020 were retrospectively reviewed. All patients underwent a preoperative CT examination and surgical treatment. The maximal EWT of the lesions on CT was measured. Patients were divided into pT1, pT2, pT3 and pT4 subgroups according to the pathologic stage. We employed the support vector machine, where linear kernels were leveraged to determine the optimal threshold to classify samples with different T stages. 90% of samples from each subgroup were randomly selected as the training set, while the remainder comprised the testing set.

Results

The mean EWTs of the pT1, pT2, pT3 and pT4 subgroups were 4.9 ± 2.6 mm, 8.1 ± 2.3 mm, 12.4 ± 3.6 mm, and 18.6 ± 4.4 mm, respectively. Differences in the EWT between the four subgroups or between adjacent subgroups were significant (p < 0.001), and esophageal wall became thicker with increasing pT stage. We utilized MATLAB 2020a to implement the SVM model and ran the code 10 times. The accuracy of the model was 60.29 ± 2.33%. The thresholds between samples from pT1/pT2, pT2/pT3 and pT3/pT4 lesions were 5.5 ± 0.3 mm, 10.8 ± 0.8 mm and 15.9 ± 0.5 mm, respectively.

Conclusions

Possibility of predicting T stage of ESCC by EWT on CT scans was limited to 60% by model examination with large sample size.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Lee H-S, Jung H-K, Tae CH, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLoS ONE. 2020;15(4):e0231456.CrossRefPubMed Lee H-S, Jung H-K, Tae CH, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLoS ONE. 2020;15(4):e0231456.CrossRefPubMed
3.
go back to reference Cai Z, Liu Q. Understanding the Global Cancer Statistics 2018: implications for cancer control. Sci China Life Sci. 2021;64(6):1017–20.CrossRef Cai Z, Liu Q. Understanding the Global Cancer Statistics 2018: implications for cancer control. Sci China Life Sci. 2021;64(6):1017–20.CrossRef
4.
go back to reference Li B, Li N, Liu S, et al. Does [18F] fluorodeoxyglucose–positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma? J Thorac Cardiovasc Surg. 2020;160(2):544–50.CrossRef Li B, Li N, Liu S, et al. Does [18F] fluorodeoxyglucose–positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma? J Thorac Cardiovasc Surg. 2020;160(2):544–50.CrossRef
5.
go back to reference Krill T, Baliss M, Roark R, et al. Accuracy of endoscopic ultrasound in esophageal cancer staging. J Thorac Dis. 2019;11(S12):S1602–9.CrossRefPubMed Krill T, Baliss M, Roark R, et al. Accuracy of endoscopic ultrasound in esophageal cancer staging. J Thorac Dis. 2019;11(S12):S1602–9.CrossRefPubMed
6.
go back to reference Choi J, Kim SG, Kim JS, et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24(6):1380–6.CrossRef Choi J, Kim SG, Kim JS, et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24(6):1380–6.CrossRef
7.
go back to reference Deng J, Chu X, Ren Z, et al. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study. Medicine. 2020;99(19):e20064.CrossRefPubMed Deng J, Chu X, Ren Z, et al. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study. Medicine. 2020;99(19):e20064.CrossRefPubMed
8.
go back to reference He LJ, Xie C, Wang ZX, et al. Submucosal saline injection followed by endoscopic ultrasound versus endoscopic ultrasound only for distinguishing between T1a and T1b esophageal cancer. Clin Cancer Res. 2020;26(2):384–90.CrossRef He LJ, Xie C, Wang ZX, et al. Submucosal saline injection followed by endoscopic ultrasound versus endoscopic ultrasound only for distinguishing between T1a and T1b esophageal cancer. Clin Cancer Res. 2020;26(2):384–90.CrossRef
9.
go back to reference Lee G, I H, Kim SJ, , et al. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT. J Nucl Med. 2014;55(8):1242–7.CrossRef Lee G, I H, Kim SJ, , et al. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT. J Nucl Med. 2014;55(8):1242–7.CrossRef
10.
go back to reference Sandha GS, Severin D, Postema E, et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc. 2008;67(3):402–9.CrossRef Sandha GS, Severin D, Postema E, et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc. 2008;67(3):402–9.CrossRef
11.
go back to reference Pfau PR, Perlman SB, Stanko P, et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc. 2007;65(3):377–84.CrossRef Pfau PR, Perlman SB, Stanko P, et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc. 2007;65(3):377–84.CrossRef
12.
go back to reference Iyer RB, Silverman PM, Tamm EP, et al. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181(3):785–93.CrossRef Iyer RB, Silverman PM, Tamm EP, et al. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181(3):785–93.CrossRef
13.
go back to reference Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol. 2003;9(2):219–24.CrossRefPubMed Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol. 2003;9(2):219–24.CrossRefPubMed
14.
go back to reference Chen M, Li X, Chen Y, et al. Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging. Radiat Oncol. 2019;14(1):54.CrossRefPubMed Chen M, Li X, Chen Y, et al. Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging. Radiat Oncol. 2019;14(1):54.CrossRefPubMed
15.
go back to reference Cheng ZZ, Yang NJ, Xi XQ, et al. Diagnostic and application value of 64-slice spiral CT scanning in preoperative staging of esophageal cancer. Zhonghua Zhong Liu Za Zhi. 2011;33(12):929–32. Cheng ZZ, Yang NJ, Xi XQ, et al. Diagnostic and application value of 64-slice spiral CT scanning in preoperative staging of esophageal cancer. Zhonghua Zhong Liu Za Zhi. 2011;33(12):929–32.
16.
go back to reference Moschetta M, Ianora AA, Marzullo A, et al. Vessel probe CT protocol in the study of esophageal carcinoma: can it improve preoperative T staging? Eur J Surg Oncol. 2010;36(7):663–9.CrossRef Moschetta M, Ianora AA, Marzullo A, et al. Vessel probe CT protocol in the study of esophageal carcinoma: can it improve preoperative T staging? Eur J Surg Oncol. 2010;36(7):663–9.CrossRef
17.
go back to reference Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol. 2005;7(6):422–30.CrossRef Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol. 2005;7(6):422–30.CrossRef
18.
go back to reference Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;181(2):419–25.CrossRefPubMed Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;181(2):419–25.CrossRefPubMed
19.
go back to reference Moss AA, Schnyder P, Thoeni RF, et al. Esophageal carcinoma: pretherapy staging by computed tomography. Am J Roentgenol. 1981;136(6):1051–6.CrossRef Moss AA, Schnyder P, Thoeni RF, et al. Esophageal carcinoma: pretherapy staging by computed tomography. Am J Roentgenol. 1981;136(6):1051–6.CrossRef
20.
go back to reference Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36–42.CrossRef Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36–42.CrossRef
21.
go back to reference Hu CY, Li YK, Li JB, et al. A comparative study of the normal oesophageal wall thickness based on 3-dimensional, 4-dimensional, and cone beam computed tomography. Medicine. 2020;99(45):e22553.CrossRefPubMed Hu CY, Li YK, Li JB, et al. A comparative study of the normal oesophageal wall thickness based on 3-dimensional, 4-dimensional, and cone beam computed tomography. Medicine. 2020;99(45):e22553.CrossRefPubMed
22.
go back to reference Panebianco V, Grazhdani H, Iafrate F, et al. 3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging? Eur Radiol. 2006;16(2):414–21.CrossRef Panebianco V, Grazhdani H, Iafrate F, et al. 3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging? Eur Radiol. 2006;16(2):414–21.CrossRef
23.
go back to reference Yamabe Y, Kuroki Y, Ishikawa T, et al. Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT. AJR Am J Roentgenol. 2008;191(3):753–7.CrossRef Yamabe Y, Kuroki Y, Ishikawa T, et al. Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT. AJR Am J Roentgenol. 2008;191(3):753–7.CrossRef
24.
go back to reference Thompson WM, Halvorsen RA Jr. Staging esophageal carcinoma II: CT and MRI. Semin Oncol. 1994;21(4):447–52. Thompson WM, Halvorsen RA Jr. Staging esophageal carcinoma II: CT and MRI. Semin Oncol. 1994;21(4):447–52.
25.
go back to reference Picus D, Balfe DM, Koehler RE, et al. Computed tomography in the staging of esophageal carcinoma. Radiology. 1983;146(2):433–8.CrossRef Picus D, Balfe DM, Koehler RE, et al. Computed tomography in the staging of esophageal carcinoma. Radiology. 1983;146(2):433–8.CrossRef
26.
go back to reference Umeoka S, Koyama T, Watanabe G, et al. Preoperative local staging of esophageal carcinoma using dual-phase contrast-enhanced imaging with multi-detector row computed tomography: value of the arterial phase images. J Comput Assist Tomogr. 2010;34(3):406–12.CrossRef Umeoka S, Koyama T, Watanabe G, et al. Preoperative local staging of esophageal carcinoma using dual-phase contrast-enhanced imaging with multi-detector row computed tomography: value of the arterial phase images. J Comput Assist Tomogr. 2010;34(3):406–12.CrossRef
27.
go back to reference Sultan R, Haider Z, Chawla TU. Diagnostic accuracy of CT scan in staging resectable esophageal cancer. J Pak Med Assoc. 2016;66(1):90–2. Sultan R, Haider Z, Chawla TU. Diagnostic accuracy of CT scan in staging resectable esophageal cancer. J Pak Med Assoc. 2016;66(1):90–2.
28.
go back to reference Walker AJ, Spier BJ, Perlman SB, et al. Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol. 2011;13(1):166–71.CrossRef Walker AJ, Spier BJ, Perlman SB, et al. Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol. 2011;13(1):166–71.CrossRef
Metadata
Title
Esophageal wall thickness on CT scans: can it predict the T stage of primary thoracic esophageal squamous cell carcinoma?
Authors
Yue Wang
Yong Huang
Qi-yu Zhao
Xiao-qin Li
Ling Wang
Ning-ning Wang
Jin-zhi Wang
Qing Wang
Publication date
01-04-2022
Publisher
Springer Singapore
Published in
Esophagus / Issue 2/2022
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-021-00886-2

Other articles of this Issue 2/2022

Esophagus 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.